More Frequent Clinic Visits Are Associated with Improved Outcomes for Children with NAFLD

Table 2

Change in laboratory values between baseline and outcome clinic visits.

	Group	Baseline	Outcome	value
ALT (U/L)	NAFLD3M	100 (90)	75 (54)	0.02
	HEP1Y	101 (81)	85 (70)	0.09
AST (U/L)	NAFLD3M	57 (43)	44 (27)	0.03
	HEP1Y	60 (35)	52 (40)	0.11
GGT (U/L)	NAFLD3M	41 (30)	31 (18)	<0.01
	HEP1Y	63 (53)	57 (48)	0.07
ALP (U/L)	NAFLD3M	247 (107)	206 (89)	<0.01
	HEP1Y	238 (95)	212 (96)	0.05
LDL (mmol/L)	NAFLD3M	2.5 (0.6)	2.5 (0.6)	0.38
	HEP1Y	2.9 (0.1)	2.7 (0.3)	0.19
HDL (mmol/L)	NAFLD3M	1.2 (0.3)	1.1 (0.3)	0.36
	HEP1Y	0.9 (0.1)	0.9 (0.1)	0.25
Total cholesterol (mmol/L)	NAFLD3M	4.4 (0.8)	4.3 (0.7)	0.19
	HEP1Y	5.2 (1.1)	5.0 (1.3)	0.53
Triglycerides (mmol/L)	NAFLD3M	1.3 (0.8)	1.4 (1.0)	0.56
	HEP1Y	2.1 (1.3)	1.7 (1.0)	0.37
PLT (×10^9/L)	NAFLD3M	288 (49)	290 (62)	0.88
	HEP1Y	326 (55)	316 (56)	0.33

Data are expressed as means (SD).